BRIEF published on 02/28/2024 at 07:30, 2 years 2 months ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years 2 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 2 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 7 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 7 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 7 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 8 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 2 years 10 months ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 2 years 10 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
PRESS RELEASE published on 05/25/2023 at 07:30, 2 years 11 months ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
Published on 05/06/2026 at 18:35, 11 minutes ago CoTec to Form an Early Stage Exploration Joint Venture with U.S. Company Copper Intelligence to Target Processing Historical Copper Tailings Opportunities in the Democratic Republic of Congo
Published on 05/06/2026 at 16:30, 2 hours 16 minutes ago Silver Spruce Resources Inc. Announces Results of Annual and Special Meeting of Shareholders
Published on 05/06/2026 at 15:25, 3 hours 21 minutes ago Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 3 hours 31 minutes ago Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 3 hours 34 minutes ago Revival Gold Announces Closing of $33 Million Brokered Private Placement
Published on 05/06/2026 at 18:30, 16 minutes ago Avolta shareholders approve all proposals of the Board at the Ordinary General Meeting 2026
Published on 05/06/2026 at 17:45, 1 hour 1 minute ago Broadpeak publie son chiffre d’affaires du premier trimestre 2026.
Published on 05/06/2026 at 17:45, 1 hour 1 minute ago Broadpeak publishes its first-quarter 2026 revenue.
Published on 05/06/2026 at 18:00, 46 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 46 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 46 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 46 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 1 hour 1 minute ago Information concerning the total number of voting rights and shares 2026 04 30
